Nearly 21 million adults and over 9 million children​ in the U.S. have eczema. This equals about 8 out of 100 adults and 13 out of 100 children.^1,2 Nearly 6.6 million adults say they have moderate-to-severe symptoms.³ Atopic dermatitis (AD) is the most common form of eczema.

October Is National Eczema Awareness Month

During October, join the Asthma and Allergy Foundation of America (AAFA) as we raise awareness of eczema. AAFA invites you to use our resources and tools to teach others what it’s like to live with eczema.

Share eczema facts:
Learn more about eczema prevalence and the costs of eczema in the United States. Download our fact sheet: Allergic Skin Conditions Facts and Figures ^{[2] [3]}

How to share images:
Click or tap on an image. Save it to your computer or mobile device. For desktop computers, right-click and “save as.” Then share the image with your friends and family via social media. Be sure to tag us!

Be sure to follow us on Facebook ^[4], Instagram ^[5], YouTube ^[6], and TikTok ^[7]!

Change Your Profile Pictures

Share Our Awareness Images

We have many shareable images throughout our website. Here are some of our favorites about eczema:

<!--View more shareable images... ^[8]-->

Watch and Share Our Awareness Videos

We hear many questions about how eczema is related to food allergy, so we asked the expert.

Watch Atopic Dermatitis and Eczema Educational Webinars

AAFA offers a variety of free webinars for people with atopic dermatitis and eczema, and their caregivers.

Watch CME Programs on Atopic Dermatitis

View our programs on atopic dermatitis. You can earn an AMA PRA Category 1 Credit™, as noted.

Disparity and Equity in Moderate-to-Severe AD Care: Enhancing Access to Multidisciplinary Care for Patients from Diverse Populations

Topics covered during this program include:

• The impacts that age, race, and ethnicity have on atopic dermatitis (AD)
• Management of moderate-to-severe atopic dermatitis
• The unique challenges that people from diverse racial and ethnic group face when attempting to access care

Please note AMA PRA Category 1 Credit™ is no longer available.

Watch on YouTube ^[11]

Endophenotypes, Evidence, and Long-Term Outcomes in Moderate-to-Severe Atopic Dermatitis Management: A Decision Library

Topics covered during this program include:

• Alignment of therapeutic decisions to clinical endophenotypes in patients of different age groups and races
• Evidence-based treatment recommendations to achieve long-term disease control
• Strategies to encourage shared-decision-making with patients

Please note AMA PRA Category 1 Credit™ is no longer available. There are four modules in this program.

Module 1

Watch on YouTube ^[12]

Module 2

Watch on YouTube ^[13]

Module 3

Watch on YouTube ^[14]

Module 4

Watch on YouTube ^[15]